Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Roche inks $200M pact for Freenome's cancer screening blood test
Roche will make a new $75 million equity investment in Freenome, toward the goal of developing blood testing kits for markets outside the U.S.
Conor Hale
Nov 21, 2025 10:55am
GE HealthCare to acquire Intelerad for $2.3B
Nov 20, 2025 4:34pm
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Nov 20, 2025 10:30am
Lumexa Imaging eyes IPO expected to raise $200M
Nov 19, 2025 12:28pm
FDA clears Dexcom's basal dosing software for Type 2 diabetes
Nov 19, 2025 9:45am
Startups at AHA tout innovative tech for heart, brain health
Nov 17, 2025 4:15pm
